Invus Advisors, L.L.C., 10% Owner at LEXICON PHARMACEUTICALS, INC./DE (LXRX), bought 15,455,145 shares at $1.50 ($23.2M) on 2009-10-14, disclosed to the SEC on 2009-10-15.
Open-market purchase of $23.2M LXRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.50 | 13,439,257 | $20.2M | 87.0% |
| 2 | $1.50 | 2,015,888 | $3.0M | 13.0% |
| Total | $1.50 avg | 15,455,145 | $23.2M | 100% |
| Filing → |
| BUFF | SELL | 2015-07-27 | $569.3M | — | Filing → |
| LXRX | BUY | 2008-05-02 | $1.3M | — | Filing → |
| LXRX | BUY | 2007-08-24 | — | — | Filing → |